Ascentage Pharma Group International American Depository Shares Cash Flow Statement
NASDAQ: AAPGHealth CareBiotechnology: Pharmaceutical PreparationsUSD
14.75+0.20 (+1.37%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ascentage Pharma Group International American Depository Shares free cash flow
In fiscal 2024, Ascentage Pharma Group International American Depository Shares generated -$15.3 million of operating cash flow and spent $3.3 million on capital expenditures. That left free cash flow of -$18.6 million, a free-cash-flow margin of -13.8% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Ascentage Pharma Group International American Depository Shares cash flow statement (annual)
| Fiscal year (USD) | FY 20242024-12-31 |
|---|---|
| Net Income | -55.58M |
| Net Income growth (YoY) | — |
| Stock-Based Compensation | 2.87M |
| Operating Cash Flow | -15.26M |
| Capital Expenditures | -3.33M |
| Investing Cash Flow | -49.60M |
| Debt Issued | 73.42M |
| Debt Repaid | -92.18M |
| Financing Cash Flow | 43.12M |
| Net Change in Cash | -21.73M |
| Free Cash Flow | -18.58M |
Values in USD; B = billions, M = millions. Fiscal periods follow AAPG's reporting calendar. What is a cash flow statement?